A Phase 3 interventional study of Adapalene and Benzoyl Peroxide Gel and Adapalene and Benzoyl Peroxide Gel (Reference) in Acne, sponsored by Padagis LLC. Completed. Open to participants aged 12 Years to 40 Years. Per ClinicalTrials.gov, last updated 2021-11-02.
Sponsored by Padagis LLC · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies testing adapalene in Acne Vulgaris — none open to participants now, 2 under way, none of them phase 3. Adapalene · Acne Vulgaris.
Among the 30 studies testing adapalene in Acne Vulgaris, this one is the 6th largest by enrollment, is one of 2 that started in 2011, is one of 9 in phase 3, and was the 18th registered.
791 studies on the registry are indexed under Acne Vulgaris; 93 are open to participants now.
Browse Acne Vulgaris studies →None of the 30 studies testing adapalene in Acne Vulgaris is open now. The open studies under Acne Vulgaris, anywhere →
Adapalene: first FDA approval 1996 (DIFFERIN). What it is approved for, and how studies give it, is on its page →
Of the 46 Acne Vulgaris studies recruiting now, 16 (35%) set no upper age limit and 29 (63%) stop at 75 or younger; 21 take children under 18; 17 take healthy volunteers.
This study: 12 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 2 · Phase 3 9 · Phase 4 11
First in 2004; this study’s year is marked. 2 started in 2011.
This study's enrollment of 903 is above the median of 70 across 673 interventional studies indexed under Acne Vulgaris.
Median enrollment 215 across the 30 interventional studies. Of the 26 that completed or were terminated, 16 (62%) have results posted.
This tab as a report to print or save as PDF → With an account.
25 of 30 have an industry lead sponsor. The 10 most frequent:
Padagis LLC is the lead sponsor of 37 studies on the registry; none are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 6 (100%) have results posted.
Padagis LLC has 6 studies filed under Acne Vulgaris — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 30 studies testing adapalene in Acne Vulgaris, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to compare the safety and bioequivalence of Perrigo's product to an FDA approved product for the treatment acne vulgaris.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Washout period
A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adapalene and Benzoyl Peroxide Gel
Drug: Adapalene and Benzoyl Peroxide Gel
Adapalene and Benzoyl Peroxide Gel (Reference)
Drug: Adapalene and Benzoyl Peroxide Gel (Reference)
Placebo gel
Drug: Placebo gel
Drug pages: Adapalene · Benzoyl Peroxide
Drug pages: Adapalene · Benzoyl Peroxide
Mean Percent Change From Baseline to Day 84 in Inflammatory (Papules and Pustules) Lesions
Time frame: 84 days
Mean Percent Change From Baseline to Day 84 in Non-inflammatory (Open and Closed Comedones) Lesions
Time frame: 84 days
| Milestone | Test Product | Reference Product | Placebo Product |
|---|---|---|---|
| Started | 365 | 360 | 178 |
| Completed | 330 | 307 | 159 |
| Not completed | 35 | 53 | 19 |
| percent change of lesion counts | Test Product | Reference Product | Placebo Product |
|---|---|---|---|
| Mean Percent Change From Baseline to Day 84 in Inflammatory (Papules and Pustules) Lesions | 61.07 ± 36.6 | 65.58 ± 28.42 | 41.63 ± 28.05 |
| percent change of lesion counts | Test Product | Reference Product | Placebo Product |
|---|---|---|---|
| Mean Percent Change From Baseline to Day 84 in Non-inflammatory (Open and Closed Comedones) Lesions | 54.33 ± 32.00 | 55.06 ± 32.62 | 36.40 ± 38.61 |
Collected over 84 Days. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Test Product | 0/365 (0%) | 0/365 (0%) | 0/365 (0%) |
| Reference Product | 0/360 (0%) | 2/360 (0.6%) | 0/360 (0%) |
| Placebo Product | 0/178 (0%) | 2/178 (1.1%) | 0/178 (0%) |
| Event | Test Product | Reference Product | Placebo Product |
|---|---|---|---|
| GastroenteritisInfections and infestations | 0/365 | 0/360 | 1/178 |
| Abortion SpontaneousPregnancy, puerperium and perinatal conditions | 0/365 | 0/360 | 1/178 |
| ConvulsionNervous system disorders | 0/365 | 1/360 | 0/178 |
| AppendicitisInfections and infestations | 0/365 | 1/360 | 0/178 |
| Age, Continuous(years) | Test Product | Reference Product | Placebo Product | Total |
|---|---|---|---|---|
| Mean | 19.9 ± 6.25 | 20.4 ± 6.96 | 19.5 ± 6.55 | 20.0 ± 6.60 |
| Sex: Female, Male(Participants) | Test Product | Reference Product | Placebo Product | Total |
|---|---|---|---|---|
| Female | 199 | 213 | 103 | 515 |
| Male | 166 | 147 | 75 | 388 |
| Ethnicity (NIH/OMB)(Participants) | Test Product | Reference Product | Placebo Product | Total |
|---|---|---|---|---|
| Hispanic or Latino | 70 | 59 | 27 | 156 |
| Not Hispanic or Latino | 295 | 301 | 151 | 747 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Test Product | Reference Product | Placebo Product | Total |
|---|---|---|---|---|
| American Indian or Alaska Native | 2 | 4 | 1 | 7 |
| Asian | 17 | 19 | 7 | 43 |
| Native Hawaiian or Other Pacific Islander | 4 | 2 | 1 | 7 |
| Black or African American | 73 | 87 | 34 | 194 |
| White | 259 | 245 | 132 | 636 |
| More than one race | 6 | 3 | 0 | 9 |
| Unknown or Not Reported | 4 | 0 | 3 | 7 |
No study locations are listed for this record.
PDFs hosted by the registry, ClinicalTrials.gov.
The record gives a start of Dec 2011, a primary completion of Aug 2012 and a completion of Aug 2012. It does not say whether these dates are actual or estimated.
Results were first posted in Jan 2021, 8 years 5 months after primary completion. A results delay was requested in Aug 2015.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Adapalene · Benzoyl Peroxide